Effective management of substance use disorder

Sarah Anwar, MDLinx

American Psychiatric Association 2018 Annual Meeting

New York, New York, United States | May 05-09, 2018

New York, NY, May 7, 2018—Screening all patients for substance use disorders should be part of all evaluations, according to Nora D. Volkow, MD, director, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, here at the American Psychiatric Association 2018 Annual Meeting.

“We have these preconceived notions about how a person suffering from a disease of addiction looks, we have an expectation, and say no. The psychiatrist may even feel uncomfortable asking the patient because addiction is stigmatized. We have to change that framework,” said Dr. Volkow.

Psychiatrists should also be prepared to prescribe buprenorphine and naltrexone (extended release also) in patients in whom they are indicated, or refer them to a methadone clinic, she added.

All Interviews

From this Conference

2:12

Distinguishing between causes of opioid use disorder to personalize treatment
New York, NY, May 7, 2018—Identifying the cause of addiction in patients suffering from substance use disorders will help psychiatrists personalize treatment and tailor...
Nora D. Volkow, MD
1:50

Managing schizophrenia: Advances and drawbacks in treatment options
With schizophrenia, the current standard of care focuses on controlling the patient’s positive symptoms, to make living with the condition manageable.
Leslie Citrome, MD, MPH
2:48

Exploring how Thirteen Reasons Why and other portrayals of suicide in the media affect young adults
After the airing of Thirteen Reasons Why, presentations for suicide in emergency departments around the country increased, according to anecdotal evidence, said Nicole Guanci,...
Nicole Guanci, MD

1:30

Adherence to antiretroviral therapy, management of depression in HIV/AIDS patients
New York, NY, May 11, 2018—Helping patients diagnosed with HIV/AIDS manage their depression can also promote better adherence to antiretroviral therapy, according to...
Jordi Blanch, MD, PhD
1:18

Preventing opioid addiction: What can clinicians do?
Reducing the number of opioid prescriptions written should be the primary focus of physicians trying to prevent and reduce the number of individuals addicted to opioids,...
Nora D. Volkow, MD
2:36

A heroin vaccine may be on the horizon
At the American Psychiatric Association 2018 Annual Meeting, Nora D. Volkow, MD, Director, National Institute on Drug Abuse, NIH, Bethesda, MD, discussed some of the novel...
Nora D. Volkow, MD

This activity is not sanctioned by, nor a part of, the American Psychiatry Association 2018 Annual Meeting.